Although a functional interaction among 5HT1A, NK1, and dopamine receptors remains unknown, the novel anti-MAO marine phlorotannins, dieckol and PFF-A, with multi-action on these receptors, are potential agents of treatment of psychological disorders and Parkinson’s disease. The gene discussed is HTR1A; the disease is Parkinson disease.